Pair Name | Phorbol 12-myristate 13-acetate, Apicularen A | ||
Phytochemical Name | Phorbol 12-myristate 13-acetate (PubChem CID: 27924 ) | ||
Anticancer drug Name | Apicularen A (PubChem CID: 10718000 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Phorbol 12-myristate 13-acetate, Apicularen A | |||
Disease Info | [ICD-11: 2C77] | Cervical cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | CASP3 | hsa836 |
Up-regulation | Expression | PARP1 | hsa142 | |
Down-regulation | Expression | PRKCA | hsa5578 | |
Down-regulation | Expression | TUBA1B | hsa10376 | |
Down-regulation | Expression | TUBB3 | hsa10381 | |
In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
Result | These results suggest that the synergy between PMA and apicularen A is involved by PKCα activation and microtubule disruption, and that may inform the development of novel approaches to treat cancer. |
No. | Title | Href |
---|---|---|
1 | PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells. BMC Cancer. 2014 Jan 22;14:36. doi: 10.1186/1471-2407-14-36. | Click |